CONMED Current Ratio 2010-2022 | CNMD

CONMED current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
CONMED Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-03-31 $0.49B $0.19B 2.60
2021-12-31 $0.46B $0.20B 2.34
2021-09-30 $0.44B $0.18B 2.42
2021-06-30 $0.44B $0.20B 2.23
2021-03-31 $0.42B $0.18B 2.33
2020-12-31 $0.42B $0.19B 2.19
2020-09-30 $0.40B $0.18B 2.26
2020-06-30 $0.38B $0.15B 2.51
2020-03-31 $0.39B $0.16B 2.46
2019-12-31 $0.40B $0.19B 2.11
2019-09-30 $0.40B $0.16B 2.48
2019-06-30 $0.40B $0.16B 2.55
2019-03-31 $0.39B $0.15B 2.58
2018-12-31 $0.37B $0.16B 2.33
2018-09-30 $0.36B $0.17B 2.20
2018-06-30 $0.35B $0.18B 1.97
2018-03-31 $0.34B $0.16B 2.15
2017-12-31 $0.36B $0.15B 2.38
2017-09-30 $0.36B $0.14B 2.56
2017-06-30 $0.34B $0.13B 2.62
2017-03-31 $0.33B $0.13B 2.66
2016-12-31 $0.33B $0.11B 2.90
2016-09-30 $0.37B $0.11B 3.27
2016-06-30 $0.37B $0.11B 3.49
2016-03-31 $0.37B $0.10B 3.57
2015-12-31 $0.36B $0.12B 3.01
2015-09-30 $0.38B $0.11B 3.44
2015-06-30 $0.37B $0.11B 3.41
2015-03-31 $0.37B $0.11B 3.30
2014-12-31 $0.38B $0.12B 3.29
2014-09-30 $0.39B $0.12B 3.17
2014-06-30 $0.39B $0.11B 3.68
2014-03-31 $0.37B $0.10B 3.64
2013-12-31 $0.37B $0.11B 3.35
2013-09-30 $0.36B $0.10B 3.61
2013-06-30 $0.36B $0.10B 3.62
2013-03-31 $0.35B $0.10B 3.64
2012-12-31 $0.35B $0.13B 2.79
2012-09-30 $0.35B $0.13B 2.75
2012-06-30 $0.34B $0.14B 2.50
2012-03-31 $0.35B $0.17B 2.12
2011-12-31 $0.36B $0.13B 2.72
2011-09-30 $0.37B $0.23B 1.59
2011-06-30 $0.37B $0.21B 1.75
2011-03-31 $0.36B $0.18B 1.98
2010-12-31 $0.35B $0.18B 1.95
2010-09-30 $0.37B $0.12B 3.14
2010-06-30 $0.35B $0.11B 3.27
2010-03-31 $0.35B $0.11B 3.34
2009-12-31 $0.33B $0.08B 4.12
2009-09-30 $0.32B $0.08B 3.91
2009-06-30 $0.29B $0.06B 4.58
2009-03-31 $0.29B $0.07B 4.44
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.878B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.707B 20.13
McKesson (MCK) United States $46.168B 13.57
AmerisourceBergen (ABC) United States $29.993B 13.84
West Pharmaceutical Services (WST) United States $21.960B 33.46
Laboratory Of America Holdings (LH) United States $21.873B 9.14
Cooper (COO) United States $15.496B 23.85
Cardinal Health (CAH) United States $14.662B 11.26
Invacare (IVC) United States $0.053B 0.00